NightWare Therapeutic Platform for improving Cardiovascular Health inAdults With Nightmares Associated with PTSD

NightWare 治疗平台可改善患有 PTSD 相关噩梦的成年人的心血管健康

基本信息

  • 批准号:
    10559634
  • 负责人:
  • 金额:
    $ 19.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Post traumatic stress disorder (PTSD) is linked to accelerated aging and is associated with increased risk of early-onset cardiovascular disease (CVD) in both men and women. PTSD is associated with premature vascular aging (i.e., large elastic arterial stiffening and vascular endothelial dysfunction) and autonomic dysfunction (e.g., reduced cardiovagal baroreflex sensitivity [cBRS] and heart rate variability [HRV]), key antecedents in the development of CVD. Sleep is important for cardiovascular health via cellular and tissue repair, free radical detoxification and reducing oxidative stress and inflammation. Nightmares, a central feature of PTSD, are a debilitating condition that can lead to sleep deprivation or insomnia, daytime sleepiness and other sequala, that ultimately causes clinically significant distress and impairment in social, occupational and cardiovascular function. As such, therapeutic strategies and interventions that address nightmare-associated sleep disturbances in individuals with PTSD is clinically important for improving sleep quality, cardiovascular health and risk for future age-associated CVD. NightWare™ digital therapeutic system is a novel smart watch application that was recently granted Breakthrough Device designation by the FDA for the treatment of nightmares in adults with PTSD. It uses machine learning to detect, track and arouse an individual out of a nightmare by sending vibrotactile feedback to a smart watch, and arousing the individual out of the nightmare without awakening and disrupting sleep. In the present R21 we are proposing a randomized, double-blind, placebo (i.e., sham intervention) controlled parallel pilot study that will provide the first clinical evidence for the efficacy of the NightWare digital therapeutic system to improve cardiovascular health outcomes in adults with nightmares associated with PTSD. An additional goal of this R21 will be to obtain exploratory mechanistic insight by which NightWare improves cardiovascular function, specifically, related to sleep quality, nitric oxide bioavailability, free radical production, oxidative stress and inflammation. We hypothesize that 6 weeks of the NightWare intervention will improve outcomes of vascular aging (e.g., large elastic arterial stiffening, vascular endothelial dysfunction) and autonomic function (cBRS, HRV) in adults with PTSD-related nightmares. The results from this pilot investigation will provide the basis for a larger randomized clinical trial that would be conducted to establish the efficacy of NightWare as a safe and effective therapeutic strategy for treating nightmares, promoting healthy vascular aging, autonomic function and reducing the risk for CVD later in life in adults with nightmares associated with PTSD.
项目概要/摘要 创伤后应激障碍 (PTSD) 与加速衰老有关,并且与以下风险增加有关: 男性和女性的早发性心血管疾病(CVD)。 PTSD 与早产有关 血管老化(即大弹性动脉硬化和血管内皮功能障碍)和自主神经 功能障碍(例如,心血管压力反射敏感性 [cBRS] 和心率变异性 [HRV] 降低),关键 CVD发展的前因。睡眠通过细胞和组织对心血管健康很重要 修复、自由基解毒、减少氧化应激和炎症。噩梦,一个核心特征 PTSD 是一种使人衰弱的疾病,可能导致睡眠不足或失眠、白天嗜睡和 其他后遗症,最终导致临床上显着的痛苦和社交、职业和损害 心血管功能。因此,解决噩梦相关的治疗策略和干预措施 PTSD 患者的睡眠障碍对于改善睡眠质量、心血管疾病具有临床重要意义。 健康状况和未来与年龄相关的 CVD 风险。 NightWare™数字治疗系统是一款新颖的智能手表 该申请最近被 FDA 授予突破性设备称号,用于治疗 患有创伤后应激障碍 (PTSD) 的成年人会做噩梦。它使用机器学习来检测、跟踪和唤醒个体 通过向智能手表发送振动触觉反馈,并将个人从噩梦中唤醒 不会唤醒和扰乱睡眠。在目前的 R21 中,我们提出了一项随机、双盲、 安慰剂(即假干预)对照平行试点研究将为该研究提供第一个临床证据 NightWare 数字治疗系统改善成人心血管健康结果的功效 与创伤后应激障碍(PTSD)相关的噩梦。 R21 的另一个目标是获得探索性机制 NightWare 改善心血管功能的见解,特别是与睡眠质量、一氧化氮相关的见解 生物利用度、自由基产生、氧化应激和炎症。我们假设 6 周 NightWare 干预将改善血管老化的结果(例如,大弹性动脉硬化、血管老化) 患有 PTSD 相关噩梦的成人的内皮功能障碍)和自主神经功能(cBRS、HRV)。这 这项试点调查的结果将为更大规模的随机临床试验提供基础 旨在确定 NightWare 作为一种安全有效的治疗策略的功效 噩梦,促进健康的血管老化、自主神经功能并降低晚年患 CVD 的风险 患有与 PTSD 相关的噩梦的成年人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerrie Moreau其他文献

Kerrie Moreau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerrie Moreau', 18)}}的其他基金

MitoQ supplementation for restoring aerobic exercise training effects on endothelial function in postmenopausal women
补充 MitoQ 恢复有氧运动训练对绝经后女性内皮功能的影响
  • 批准号:
    10686453
  • 财政年份:
    2022
  • 资助金额:
    $ 19.44万
  • 项目类别:
NightWare Therapeutic Platform for improving Cardiovascular Health inAdults With Nightmares Associated with PTSD
NightWare 治疗平台可改善患有 PTSD 相关噩梦的成年人的心血管健康
  • 批准号:
    10351054
  • 财政年份:
    2022
  • 资助金额:
    $ 19.44万
  • 项目类别:
Cardiovascular Consequences of Hypogonadism in Men
男性性腺功能减退症的心血管后果
  • 批准号:
    9206973
  • 财政年份:
    2016
  • 资助金额:
    $ 19.44万
  • 项目类别:
Biological Mechanisms of Vascular Dysfunction with Age and Estrogen Deficiency
年龄和雌激素缺乏导致血管功能障碍的生物学机制
  • 批准号:
    8732808
  • 财政年份:
    2013
  • 资助金额:
    $ 19.44万
  • 项目类别:
Cardiometabolic Consequences of the Loss of Ovarian Function
卵巢功能丧失的心脏代谢后果
  • 批准号:
    10712609
  • 财政年份:
    2012
  • 资助金额:
    $ 19.44万
  • 项目类别:
BIOLOGICAL MECHANISMS OF ARTERIAL STIFFENING WITH AGE AND ESTROGEN
年龄和雌激素导致动脉硬化的生物学机制
  • 批准号:
    7719538
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
SEX HORMONE REGULATION OF LARGE ARTERY STIFFNESS IN MEN
性激素对男性大动脉僵硬的调节
  • 批准号:
    7719481
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
HRT AND EXERCISE EFFECTS ON CENTRAL ARTERIAL COMPLIANCE
激素替代疗法和运动对中央动脉顺应性的影响
  • 批准号:
    7719504
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
HRT AND EXERCISE EFFECTS ON CENTRAL ARTERIAL COMPLIANCE
激素替代疗法和运动对中央动脉顺应性的影响
  • 批准号:
    7719544
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
HRT AND EXERCISE EFFECTS ON CENTRAL ARTERIAL COMPLIANCE
激素替代疗法和运动对中央动脉顺应性的影响
  • 批准号:
    7604454
  • 财政年份:
    2007
  • 资助金额:
    $ 19.44万
  • 项目类别:

相似海外基金

EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Continuing Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
  • 批准号:
    23H01186
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了